Susan Walter
Nurse Practitioner · Pine Mountain, GANPI 1184826638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $944 and has fallen 96.2% since, to $36 in 2025.
Across 132 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$311
- Pfizer$157
- AstraZeneca$156
- Lilly USA, LLC$155
- Novo Nordisk$142
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$138
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,075100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $311 |
| Pfizer | 9 | $157 |
| AstraZeneca | 11 | $156 |
| Lilly USA, LLC | 10 | $155 |
| Novo Nordisk | 8 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $138 |
| Astellas Pharma US Inc | 8 | $108 |
| Dexcom, Inc. | 7 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $98 |
| Medtronic | 5 | $78 |
| Biohaven Pharmaceuticals, Inc. | 4 | $73 |
| Biogen | 3 | $68 |
| Johnson & Johnson | 4 | $55 |
| Merck | 3 | $54 |
| AbbVie | 3 | $43 |
| Sunovion Pharmaceuticals Inc. | 4 | $41 |
| Bayer | 2 | $34 |
| Mylan Specialty L.p. | 2 | $28 |
| Smith+Nephew | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Corcept Therapeutics | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| GSK | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Boston Scientific | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Nevro Corp. | 1 | $12 |
How this compares
$2,075 in reported general payments places this provider in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $26,309 |
| MounjaroTirzepatide | 13 | $13,026 |
| XareltoRivaroxaban | 15 | $10,436 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $6,834 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 17 | $778 |
| Atorvastatin Calcium | 75 | $452 |
| Gabapentin | 26 | $384 |
| Irbesartan | 15 | $357 |
| Levothyroxine Sodium | 31 | $334 |
| Tramadol Hcl | 21 | $332 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $320 |
| Pantoprazole Sodium | 38 | $319 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $316 |
| Omeprazole | 33 | $309 |
| Rosuvastatin Calcium | 34 | $307 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $142 | $26,30924 claims |
| Lilly USA, LLCMounjaro | $155 | $13,02613 claims |
| Johnson & JohnsonXarelto | $55 | $10,43615 claims |
| GSKTrelegy Ellipta | $21 | $6,83413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Pine Mountain
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
- Luis PoloSavannah$70K
- Karen BauerDecatur$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.